Key result
Palliative chemotherapy yields transient ~18% tumor reduction in unresectable metastatic cardiac liposarcoma.
Why the study?
Cardiac involvement from dedifferentiated liposarcoma is exceedingly rare and presents significant diagnostic and therapeutic challenges.
Case Report (n=1)
No
This case report highlights the critical role of multimodality imaging, especially cardiovascular magnetic resonance, in noninvasively diagnosing rare late cardiac metastasis of dedifferentiated liposarcoma when biopsy and surgical resection are unfeasible.
Answers are grounded in this paper and cite their sources.
May offer temporary control in select unresectable cases; leaves open the role of systemic therapy in cardiac liposarcoma metastases.
Dedifferentiated liposarcoma (DDLPS) is a rare and aggressive subtype of soft tissue sarcoma, most commonly arising in the extremities or retroperitoneum. Cardiac involvement, whether primary or metastatic, is exceedingly rare and presents significant diagnostic and therapeutic challenges. We present the case of a 68-year-old woman with a history of lower limb DDLPS who experienced progressive dyspnea and was subsequently found to have a large mediastinal mass with pericardial involvement. Cardiovascular magnetic resonance (CMR) revealed imaging features consistent with a malignant lesion, including heterogeneous enhancement and tissue characteristics indicative of sarcoma. Given the patient's oncological history and the imaging findings, a diagnosis of metastatic cardiac DDLPS was favored. Surgical resection was deemed infeasible due to extensive pericardial involvement, and the patient underwent multiple lines of chemotherapy. Although there was initial disease control, she ultimately succumbed to septic shock resulting from a urinary tract infection. This case emphasizes the importance of considering metastatic sarcoma in the differential diagnosis of cardiac masses, particularly in patients with a known history of soft tissue malignancy. It also highlights the diagnostic value of CMR and the necessity for multidisciplinary management in complex, nonresectable cases.
No takes yet. Share an insight, caveat, or question.
Alizadehasl et al. (2026) conducted a case report in Metastatic cardiac dedifferentiated liposarcoma (DDLPS) with pericardial involvement (n=1). Multimodality imaging (CMR, CT, echocardiography, PET) and palliative systemic chemotherapy (doxorubicin, gemcitabine, docetaxel, pazopanib, ifosfamide) was evaluated on Tumor response and clinical survival. Palliative chemotherapy achieved an initial 15%-20% tumor size reduction in a 68-year-old woman with unresectable cardiac metastatic liposarcoma before progression and death from septic shock.
Synapse has enriched 10 related papers. Consider them for comparative context: